VY7523-102

· Voyager Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VY7523-102, covering 2025-11-19 to 2025-11-19. Get the full timeline:

Most recent: Clinical Trial Update: VY7523-102: Randomized, Placebo-Controlled, Double-Blind, Multiple Ascending Dose Study in Participants With Early Alzheimer's Disease [Phase 1, Phase 2]

See pricing